Suppr超能文献

人干扰素对严重急性呼吸综合征病毒复制的体外抑制作用

In vitro inhibition of SARS virus replication by human interferons.

作者信息

Dahl Helena, Linde Annika, Strannegård Orjan

机构信息

Swedish Institute for Infectious Disease Control, Stockholm, Sweden.

出版信息

Scand J Infect Dis. 2004;36(11-12):829-31. doi: 10.1080/00365540410021144.

Abstract

Four different types of human interferon, interferon-beta (IFN-beta), recombinant IFN-alpha2a and IFN-alpha2b and natural IFN-alpha were tested for antiviral activity against SARS-coronavirus. The experiments were performed using in vitro cultivated monkey Vero E6 cells. IFN-beta was found to be the most highly active antiviral agent, followed by natural IFN-alpha, whereas the 2 recombinant IFN-alpha2 species were poorly active in the system used. These results suggest that IFN-beta as well as natural IFN-alpha may be used for the treatment of SARS.

摘要

对四种不同类型的人干扰素,即β干扰素(IFN-β)、重组α2a干扰素、重组α2b干扰素和天然α干扰素,进行了抗严重急性呼吸综合征冠状病毒(SARS冠状病毒)的抗病毒活性测试。实验使用体外培养的猴肾Vero E6细胞进行。结果发现,IFN-β是活性最高的抗病毒剂,其次是天然α干扰素,而两种重组α2干扰素在所用系统中活性较差。这些结果表明,IFN-β以及天然α干扰素可用于治疗SARS。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验